Related Experiment Video
Updated: Aug 30, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
New treatments for perioperative cardiac arrhythmias
Laura A Hastings1, Jeffrey R Balser
1Department of Anesthesiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA.
Insights
Cardiac arrhythmias are a significant risk for surgical patients. Further research into perioperative proarrhythmic substrates is needed to guide antiarrhythmic drug therapy.
Area of Science:
- Cardiology
- Perioperative Medicine
- Pharmacology
Background:
- Cardiac arrhythmias contribute significantly to surgical patient morbidity and mortality.
- Existing research on cardiac arrhythmia management primarily focuses on out-of-hospital cardiac arrest scenarios.
- There is a gap in understanding the specific proarrhythmic factors in the surgical population.
Purpose of the Study:
- To highlight the need for research into cardiac arrhythmias in surgical patients.
- To identify the unique proarrhythmic substrates relevant to the perioperative period.
- To establish a rationale for perioperative antiarrhythmic drug therapy.
Main Methods:
- Review of recent studies on cardiac arrhythmia management.
- Analysis of knowledge gaps concerning surgical patients.
- Identification of proarrhythmic substrates in the perioperative setting.
Main Results:
- Cardiac arrhythmias pose a major threat to surgical patient outcomes.
- Current knowledge on arrhythmia management is largely derived from non-surgical contexts.
- Specific proarrhythmic substrates in surgical patients are not well-defined.
Conclusions:
- Further investigation into perioperative proarrhythmic substrates is crucial.
- Developing targeted antiarrhythmic drug strategies for surgical patients requires dedicated research.
- Understanding unique patient factors is key to improving perioperative cardiac care.
Abstract:
Cardiac arrhythmias remain a major source of morbidity, mortality, and prolonged postoperative hospital stay in surgical patients. Recent studies in patients experiencing out-of-hospital cardiac arrest have expanded our knowledge in the management of cardiac arrhythmias. Future advances require additional studies focused on the unique proarrhythmic substrates in surgical patients, to provide a clear rationale for antiarrhythmic drug therapy in the perioperative period.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy VII: Pre and Post Operative Nursing Management

